Strategic partnerships Synnovis is a joint venture among SYNLAB UK & Ireland and two NHS foundation trusts, highlighting a collaborative model that could be expanded with additional NHS partners or private clinical networks to grow test volumes and service offerings.

High testing volume With over 32 million pathology tests per year across a regional network, there is substantial demand and potential for scaled support, managed services, or enhanced workflow automation solutions to improve throughput and precision.

Advanced diagnostics Recent engagement in liquid biopsy testing and AI-driven collaborations positions the company at the forefront of precision medicine, presenting opportunities to cross-sell next-generation diagnostics, data analytics, and AI-enabled decision support tools.

Security and resilience Past ransomware incidents and data breaches indicate a critical need for robust cyber security, data protection, and incident response services to safeguard patient data and sustain trust with NHS stakeholders.

Growth through innovation Active partnerships with universities and tech firms suggest a pathway for joint research, piloting new assays, and expanding into genomic and liquid biopsy services to capture broader NHS funding and commercialization opportunities.